Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) was $7.49 for the day, down -1.06% from the previous closing price of $7.57. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 1.1 million shares were traded. BCRX stock price reached its highest trading level at $7.55 during the session, while it also had its lowest trading level at $7.42.
Ratios:
Our analysis of BCRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.78 and its Current Ratio is at 2.82.
On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.
Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 24 ’24 when McKee Amy E sold 8,600 shares for $6.32 per share. The transaction valued at 54,352 led to the insider holds 27,831 shares of the business.
SANDERS MACHELLE sold 4,689 shares of BCRX for $28,134 on Jun 17 ’24. The Director now owns 27,742 shares after completing the transaction at $6.00 per share. On Jun 14 ’24, another insider, HEGGIE THERESA, who serves as the Director of the company, sold 6,698 shares for $6.11 each. As a result, the insider received 40,925 and left with 52,852 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1549576064 and an Enterprise Value of 2128189696. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.05. Its current Enterprise Value per Revenue stands at 5.568 whereas that against EBITDA is -40.376.
Stock Price History:
Over the past 52 weeks, BCRX has reached a high of $8.88, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is -3.94%, while the 200-Day Moving Average is calculated to be 18.20%.
Shares Statistics:
BCRX traded an average of 2.05M shares per day over the past three months and 1427530 shares per day over the past ten days. A total of 205.77M shares are outstanding, with a floating share count of 195.87M. Insiders hold about 5.32% of the company’s shares, while institutions hold 82.44% stake in the company. Shares short for BCRX as of 1727654400 were 23230798 with a Short Ratio of 11.33, compared to 1724976000 on 24060499. Therefore, it implies a Short% of Shares Outstanding of 23230798 and a Short% of Float of 11.3199994.
